Newsfeeds Archive - Spark Newswire

1 minute read

Three Publications Demonstrate Bionano’s OGM’s Utility For Cell And Gene Therapy; Publications Include Niño Jesús University Children’s Hospital; Ruhr-University Bochum And Janssen

May 21, 8:09 AM

Three peer-reviewed publications collectively illustrate the building support for optical genome mapping (OGM) as a tool for cell and gene therapy development that allows researchers in academic medical centers and

BNGO

1 minute read

Bionano Announces Publication Showing OGM’s High Resolution Structural Variation Detection In Cancer Validated By Cas9-Directed Nanopore Sequencing

By Benzinga Newsdesk

April 24, 8:14 AM

Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the results of an implementation study conducted by researchers at University Medical Center Groningen that compared optical genome mapping (OGM) to traditional

BNGO

2 minute read

Bionano Announces Publication Showing That OGM Detects Over 1250 Structural Variants, Including 56 Gene Fusions, In Pediatric Leukemia That Were Missed By Whole Genome Sequencing

By Benzinga Newsdesk

April 11, 8:16 AM

Bionano Genomics, Inc. (NASDAQ:BNGO) today announced the publication of a study from Penn State College of Medicine that used optical genome mapping (OGM) to search for clinically and biologically relevant genomic

BNGO

2 minute read

How Is The Market Feeling About Bionano Genomics?

By Benzinga Insights

January 26, 10:30 AM

Bionano Genomics’s (NYSE:BNGO) short percent of float has fallen 3.29% since its last report. The company recently reported…

BNGO

1 minute read

Bionano Publishes Interim Readout From Second Phase Of Clinical Trial Analyzing Optical Genome Mapping As Standard Of Care For Prenatal Testing

By Benzinga Newsdesk

January 24, 9:13 AM

Pre-print publication from Levy, et al. describes the second phase of a multisite evaluation and validation of optical genome mapping (OGM) that is designed to measure the workflow's accuracy and clinical

BNGO

3 minute read

Bionano Announces Full Commercial Release Of The Stratys System For High Throughput Optical Genome Mapping

By Benzinga Newsdesk

January 23, 9:13 AM

Bionano has completed the early access program for the Stratys™ system and is now making it available in a full commercial release The Stratys instrument can enable up to a four-fold increase in raw data

BNGO

1 minute read

Bionano Announces Peer-Reviewed Publication From Its Clinical Study Designed To Support OGM As Part Of Standard Of Care In Genetic Disease Testing

By Benzinga Newsdesk

January 11, 5:04 PM

Peer-reviewed publication from Broeckel, et al. describes the second phase of a multisite evaluation of optical genome mapping (OGM) in 627 samples (597 unique samples and 30 replicates) Overall, for the entire

BNGO

4 minute read

Bionano Reports Preliminary Q4 And FY23 Results; Sees Q4 Revenue $10.4M-$10.7M Vs $10.54M Est.; FY23 Revenue $35.8M-$36.1M Vs $35.94M Est.; Achieved All Full-Year 2023 ELEVATE Milestones

By Benzinga Newsdesk

January 8, 9:13 AM

Preliminary Q4 2023 revenue expected to be between $10.4 and $10.7 million, which would represent an estimated increase of 27% to 30% over Q4 2022 Reached installed base of 326 optical genome mapping (OGM) systems

BNGO

2 minute read

Bionano Announces Publication Of Largest Prospective Prenatal Study Comparing OGM To Chromosomal Microarray Analysis And Karyotyping

By Happy Mohamed

December 26, 9:13 AM

Key findings from prospective evaluation of 200 prenatal samples: Optical genome mapping (OGM) detected pathogenic structural variants (SVs) in 20.5% of samples (41/200); combination of chromosomal

BNGO

2 minute read

News

Bionano Genomics Announces Cancers Journal Publishes Special Issue Dedicated To OGM’s Impact On Hematological Malignancy Research

By Benzinga Newsdesk

December 14, 9:17 AM

Bionano Genomics, Inc. (NASDAQ:BNGO), today announced the publication of a special issue of Cancers journal entirely dedicated to the Company's optical genome mapping (OGM) workflow. The issue, which features guest

BNGO